ArticleThe journal of headache and pain2023

Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway.

Zifan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.